NeoGenomics (NASDAQ:NEO) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.21) by 33.33 percent. This is a 75 percent decrease over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $128.78 million which beat the analyst consensus estimate of $121.54 million by 5.96 percent. This is a 6.13 percent increase over sales of $121.34 million the same period last year.
National Research Q2 EPS $0.33 Down From $0.35 YoY, Sales $37.30M Up From $36.42M YoY
National Research (NASDAQ:NRC) reported quarterly earnings of $0.33 per share. This is a 5.71 percent decrease over earnings of $0.35 per share from the same period last year. The company reported $37.30 million in
